Beam Therapeutics inks deal with Pfizer worth up to $1.35B By: Boston Business Journal via Business Journals January 10, 2022 at 06:18 AM EST The Cambridge-based gene-editing firm has signed a four-year deal worth up to $1.35 billion with pharmaceutical giant Pfizer Inc. Read More >>
